2012		2013		2014		Rate(Cases per 100,000 per quarter)		Quarterly Rate Comparison
Disease	Q3 No.	YTD No.	Q3 No.	YTD No.	Q3 No.	YTD No.	Qtr3 (2009-2013 aggregated)	Qtr3 (2014)	Significant change bet. current & past 5-year?~~
VACCINE PREVENTABLE
DIPHTHERIA	0	0	0	0	0	0	0.00	0.00
HAEMOPHILUS INFLUENZA (INVASIVE)	1	10	0	8	5	11	0.08	0.25
HEPATITIS A	0	5	4	12	1	4	0.12	0.05
HEPATITIS B (ACUTE)	6	20	5	18	1	13	0.33	0.05	X
INFLUENZA**	5	361	6	515	11	513	10.77	0.54	X
MEASLES	0	0	0	0	0	0	0.02	0.00
MUMPS	0	0	1	1	1	2	0.03	0.05
PERTUSSIS	37	65	41	110	5	45	0.94	0.25	X
POLIOMYELITIS	0	0	0	0	0	0	0.00	0.00
RUBELLA	0	0	0	0	0	0	0.00	0.00
TETANUS	0	0	0	0	0	0	0.00	0.00
SEXUALLY TRANSMITTED
AIDS	46	152	54	160	45	160	2.63	2.21
CHLAMYDIA	2152	6451	2489	7083	1958	6087	115.86	96.37	X
GONORRHEA	554	1431	602	1654	593	1633	25.98	29.19
HIV	46	164	78	203	67	214	3.11	3.30
SYPHILIS (EARLY LATENT)	47	135	57	165	69	214	2.22	3.40	X
SYPHILIS (PRIMARY & SECONDARY)	25	65	54	116	51	179	1.69	2.51
ENTERICS
AMEBIASIS	2	5	2	6	1	1	0.08	0.05
BOTULISM-INTESTINAL (INFANT)	0	0	0	0	0	0	0.00	0.00
CAMPYLOBACTERIOSIS	22	67	31	70	32	77	1.44	1.57
CHOLERA	0	0	0	0	0	0	0.00	0.00
CRYPTOSPORIDIOSIS	1	4	3	6	0	2	0.16	0.00	X
GIARDIA	26	52	17	44	7	25	0.99	0.34	X
ROTAVIRUS	19	51	5	81	5	47	0.58	0.25
SALMONELLOSIS	50	121	47	328	46	89	2.60	2.26
SHIGA-TOXIN PRODUCING E. COLI#	17	36	19	42	8	16	0.65	0.39
SHIGELLOSIS	30	42	27	39	9	18	1.25	0.44	X
TYPHOID FEVER	0	1	0	0	0	2	0.03	0.00
VIBRIO (NON-CHOLERA)	3	3	1	3	0	1	0.09	0.00	X
YERSINIOSIS	0	1	4	7	0	1	0.04	0.00
OTHER
ANTHRAX	0	0	0	0	0	0	0.00	0.00
BOTULISM INTOXICATION	0	0	0	0	0	0	0.00	0.00
BRUCELLOSIS	0	0	0	0	0	0	0.00	0.00
COCCIDIOIDOMYCOSIS	27	89	17	54	8	44	0.91	0.39
DENGUE FEVER	1	1	0	1	0	2	0.05	0.00	X
ENCEPHALITIS	1	1	0	2	1	1	0.01	0.05
HANTAVIRUS	0	0	0	0	0	0	0.00	0.00
HEMOLYTIC UREMIC SYNDROME (HUS)	0	0	0	0	0	1	0.00	0.00
HEPATITIS C (ACUTE)	0	4	1	3	0	1	0.01	0.00
HEPATITIS D	0	0	0	0	0	0	0.00	0.00
INVASIVE GROUP A STREP.##	0	0	0	0	0	0	0.01	0.00
LEGIONELLOSIS	5	11	8	15	10	16	0.24	0.49
LEPROSY (HANSEN’S DISEASE)	0	0	0	0	0	1	0.00	0.00
LEPTOSPIROSIS	0	0	0	0	0	0	0.00	0.00
LISTERIOSIS	0	1	1	2	0	3	0.02	0.00
LYME DISEASE	0	3	5	7	2	3	0.06	0.10
MALARIA	0	1	2	5	3	5	0.08	0.15
MENINGITIS, ASEPTIC/VIRAL	6	14	19	35	12	31	0.56	0.59
MENINGITIS, BACTERIAL	1	3	1	6	3	9	0.10	0.15
MENINGOCOCCAL DISEASE	0	2	0	0	0	2	0.02	0.00
PLAGUE	0	0	0	0	0	0	0.00	0.00
PSITTACOSIS	0	0	0	0	0	0	0.00	0.00
Q FEVER	0	0	0	0	0	0	0.02	0.00
RABIES (HUMAN)	0	0	0	0	0	0	0.00	0.00
RELAPSING FEVER	0	0	0	0	0	0	0.00	0.00
ROCKY MOUNTAIN SPOTTED FEVER	0	0	0	0	0	0	0.00	0.00
RSV (RESPIRATORY SYNCYTIAL VIRUS)	14	790	11	1177	18	611	1.85	0.89	X
STREPTOCOCCUS PNEUMONIAE, IPD###	5	34	9	41	15	64	0.33	0.74
TOXIC SHOCK SYN	0	0	0	0	0	0	0.00	0.00
TOXIC SHOCK SYN (STREPTOCOCCAL)	0	3	1	3	1	9	0.01	0.05
TUBERCULOSIS	16	54	19	58	20	56	1.00	0.98
TULAREMIA	0	0	0	0	0	0	0.00	0.00
UNUSUAL ILLNESS	0	0	0	0	0	0	0.00	0.00
WEST NILE VIRUS (ENCEPHALITIS)	4	4	4	8	2	2	0.23	0.10
WEST NILE VIRUS (FEVER)	2	2	0	1	0	0	0.05	0.00	X

*Rate denominators were spline-interpolated population estimates/projections based on demographic data subject to ongoing revision by the state demographer (last revision as of Oct-2013). Use of onset date to count OOE-reported cases (since Jan-2013) causes changes in cases reported here from previously released reports. Numbers are provisional including confirmed, probable and suspect (since Feb-08) cases. HIV/AIDS case counts provided by Office of HIV/AIDS/STD; TB case counts provided by TB clinic. Quarterly disease total reported by OOE=207(reported total=3010). Due to unavailability of current birth data, congenital syphilis rates were not calculated(reported quarterly cases for 2012-2014 were respectively 0,0,1; YTD totals 0,2,2).

**Reporting of novel type A influenza (reclassified as INFLU OUTBRK per CDC recommendations as of Jan-11) started in May-09.

#E. COLI O157:H7 instead of STEC was reported prior to 2006.

##Reported since Mar-07.

###S. pneumo invasive diseases (reported since Sep-05) previouly reported under separate categories grouped together as of Jan-11 per CDC recommendations.

~~Confidence intervals (not shown) for the quarterly disease incidence rates provided a basis for an informal statistical test to determine if the current quarterly rates changed significantly from those of the previous 5 years aggregated. Text in green where rates decreased and in red where rates increased. Statistically significant changes indicated by ‘X’ (rate comparisons made if 5+ cases reported in the current quarter of this year or previous 5 years aggregated).